Sept 4 (Reuters) - Eli Lilly and Co :
* LILLY AND EVA PHARMA COLLABORATE TO EXPAND ACCESS TO BARICITINIB IN LOW- TO MIDDLE-INCOME COUNTRIES
* ELI LILLY: AGREEMENT TO EXPAND ACCESS TO BARICITINIB TO ESTIMATED 20,000 PEOPLE IN 49 LOW- TO MIDDLE-INCOME COUNTRIES IN AFRICA BY 2030
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments